LEETRO
430425
Geovis Insighter Technology
920116
Beijing Global Safety Technology
300523
Zhejiang JW Precision Machinery
300984
Wintao Communications
301139
CN Stock MarketDetailed Quotes
300142 Walvax Biotechnology
- 11.73
- -0.16-1.35%
Market Closed Mar 5 15:00 CST
18.76BMarket Cap152.34P/E (TTM)
11.89High11.62Low190.96KlotVolume11.88Open11.89Pre Close223.30MTurnover1.23%Turnover Ratio44.77P/E (Static)1.60BShares19.1552wk High1.96P/B18.29BFloat Cap9.7852wk Low14.27Limit Up1.56BShs Float96.68Historical High9.51Limit Down2.27%Amplitude3.57Historical Low0.01Dividend TTM11.69Avg Price99.17KlotAsk0.09%Div YieldTTM100Lot Size81.63KlotBid
Walvax Biotechnology News
Watson Biotech: Announcement on ending clinical research on adsorption of acellular haemophilus influenzae type b combination vaccine
Watson Biotech: Announcement on acceptance of clinical research applications for 20-valent pneumococcal polysaccharide conjugate vaccine
Watson Biotech: 2024 Annual Results Forecast
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20241226
Watson Biotech: Announcement on receiving the “Drug Clinical Trial Approval Notice” for adsorbed tetanus vaccine
Watson Biotech: Prompt Announcement for the Disclosure of the 2024 Third Quarter Report
Watson Biotech: Internal Reporting System for Important Information (October 2024)
Watson Biotech: Announcement on the calculation of credit impairment preparations and asset impairment preparations for the third quarter of 2024
Watson Biotech: Investor Relations Management System (October 2024)
Watson Biotech: Announcement of Resolutions of the 24th Meeting of the Fifth Board of Directors
Watson Biotech: Information Disclosure Management System (October 2024)
Watson Biotech: Q3 2024 Report
Watson Biotech: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Supervisors
Watson Biotech: Announcement on the subsidiary receiving the Oman Product Registration Certificate for the 13-valent pneumococcal polysaccharide conjugate vaccine
Watson Biotech: Announcement on the subsidiary receiving a license to market the bivalent HPV vaccine in Indonesia
Watson Biotech: Notice on Completing the Registration of Business Changes
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240905
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240903
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240830
Watson Biotech: Announcement on the Company\'s Receipt of an Invention Patent Certificate
